Warning letters and recalls for supplements and cosmetics.
A weekly email of FDA warning letters, recalls and import alerts for dietary supplements and cosmetics. Each row is tagged and links to its FDA source.The sample on this page is five recent warning letters and five recent recall listings. Import-alert rows are added in the subscriber feed, which is still being built.
Checkout is not open yet.
Not legal advice; source records from FDA. FDA Supplement Watch is not affiliated with or endorsed by the U.S. Food and Drug Administration. Contact (inbox being set up): hello@fdasupplementwatch.com.
- Warning letters
- Penn Herb Company, Ltd.cGMP 111Ashwagandha, sarsaparilla, black walnut hulls · Oct 19
- Psyched Wellness Ltd.New dietary ingredientCalm, Calmer and Santa (Amanita muscaria) · Sep 29
- BioDrive, Inc.AdulteratedEvolv GLP-1 Biomimetic (EV-1 peptide) · Aug 24
- American Pharma Mfg. Inc.cGMP 111Dietary supplements manufactured at the facility · Aug 4
The FDA record, already sorted for this industry.
Supplements and cosmetics, not the whole FDA docket
Warning letters, recalls and import alerts limited to dietary supplements and cosmetics — not the broader drug and device quality docket.
Tagged by ingredient and claim type
Rows carry the ingredient and the issue as they appear in the record — cGMP 111, unapproved new drugs, undeclared ingredients, and names such as kratom alkaloids or NMN when the source names them.
A weekly email, every row linked
A weekly digest with the full list as a CSV. Each line links to the FDA warning letter or the openFDA recall record it came from. We do not rehost the underlying documents.
Recent records, shortened
Five FDA warning letters and five dietary-supplement recall listings, with letter issue dates and recall report dates from Apr 7 to Oct 28, 2026. Newest first in each group.
- Window
- Apr 7 – Oct 28, 2026
- Delivery
- Weekly email digest
- Source
- FDA.gov warning letters (public domain) and openFDA food enforcement (CC0)
| Firm | Product / subject | Issue | Class | Date |
|---|---|---|---|---|
| Warning letters5 records | ||||
| Penn Herb Company, Ltd.CMS 734317 | Ashwagandha Root, Mexican Sarsaparilla Root, Black Walnut HullsSerious violations of 21 CFR Part 111 (cGMP for dietary supplements). | cGMP 111 | Oct 19 | |
| Psyched Wellness Ltd.CMS 730137 | Calm, Calmer and Santa (Amanita muscaria extract)Adulterated dietary supplements containing a new dietary ingredient, Amanita muscaria. | New dietary ingredient | Sep 29 | |
| BioDrive, Inc.CMS 731846 | Evolv GLP-1 Biomimetic (Saccharomyces cerevisiae S288C EV-1 Peptide)Dietary supplement / adulterated. Letter concerns the EV-1 peptide dietary ingredient. | Adulterated | Aug 24 | |
| American Pharma Mfg. Inc.CMS 728227 | Dietary supplement products manufactured at the facilityCGMP / dietary supplement / adulterated / misbranded (21 CFR Part 111). | cGMP 111 | Aug 4 | |
| Nature’s Elements, Inc.CMS 719302 | He Shou Wu, DHT Blocker, Cordyceps, Maitake Mushroom, D-Aspartic Acid (Monster T)CGMP / dietary supplement / adulterated / misbranded (21 CFR Part 111). Letter also cites unapproved new drugs. | cGMP 111; unapproved new drugs | Apr 7 | |
| Recalls5 records | ||||
| Evexias Health SolutionH-0170-2027 | Evexias Health Solutions Amino Ultra, 90-capsule dietary supplementThe product is mislabeled and fails to declare fish oil. | Undeclared fish oil | II | Oct 28 |
| Primal Supplements Group LLCH-0172-2027 | Primal Herbs Volume, herbal supplement, 8.5 ozFDA laboratory analysis confirmed that Primal Herbs Volume contains sildenafil not listed on the product label. | Undeclared sildenafil | I | Oct 28 |
| Pacific Health Sciences LLCH-0168-2027 | Babies' Magic Tea; Baby Sleep Gripe Water, dietary supplement, 4 ozAdulterated (elevated levels of alcohol) infant dietary supplement. | Elevated alcohol | II | Oct 28 |
| A&P CreationsH-0016-2027 | X10 Natural Enhancement Supplement, 0.5 fl oz sachetsProduct contains undeclared Sildenafil and Tadalafil. | Undeclared sildenafil and tadalafil | I | Oct 14 |
| ZMB EnterprisesH-1263-2026 | Addall XR Shot, liquid dietary supplement, 2 fl ozThe product contains 1,4-DMAA, phenylethylamine and phenibut. | 1,4-DMAA; phenylethylamine; phenibut | I | Sep 2 |
Showing 10 of 10 sample records. Warning-letter dates are the letter issue dates. Recall dates are the openFDA report dates. Import-alert rows are not in this sample. Pulled Nov 20, 2026, America/New_York.
Warning letters: FDA warning letters, public domain under FDA website policies; the list page was marked current as of Nov 20, 2026. Recalls: openFDA food enforcement, CC0 1.0; openFDA last updated 2026-11-11 (the field has no time zone). Product names are shortened; we do not rehost letters or recall files. FDA Supplement Watch is not affiliated with or endorsed by the U.S. Food and Drug Administration. Not legal advice; source records from FDA. Matters in a warning letter may have changed after it was posted.
Pricing
One plan, $39 a month, renewing automatically. Cancel anytime from the Stripe link in your receipt; cancellation takes effect at the end of the paid period.
Subscription
One plan, billed monthly.
- Weekly email digest of FDA warning letters, recalls and import alerts
- Limited to dietary supplements and cosmetics
- Ingredient and claim-type tags
- Every row linked to its FDA source
- Full list as CSV
Checkout is not open yet.
Not legal advice; source records from FDA. FDA Supplement Watch is not affiliated with or endorsed by the U.S. Food and Drug Administration. Contact (inbox being set up): hello@fdasupplementwatch.com.
Questions
What is in the digest?
FDA warning letters, recalls and import alerts that apply to dietary supplements and cosmetics. Records are tagged by ingredient and by claim type (for example cGMP 111 or unapproved new drugs) when the source names them. Each row links to the FDA record. The sample on this page is five recent warning letters and five recent recall listings; import-alert rows are added in the subscriber feed, which is still being built.
Is this legal or compliance advice?
No. Not legal advice; source records from FDA. A row means a public FDA record was posted. Warning letters can be followed by later correspondence that changes the status of the issues they discuss. Check the linked record before you act.
Is this an FDA website?
No. FDA Supplement Watch is not affiliated with or endorsed by the U.S. Food and Drug Administration. We republish public FDA records and link back to them. FDA.gov material is in the public domain; openFDA data is dedicated to the public domain under CC0 1.0.
Where does the data come from?
Warning letters from the FDA warning-letters list (fda.gov), which is public domain. Recalls from the openFDA food enforcement API, dedicated to the public domain under CC0 1.0 (last updated 2026-11-11 in the file we pulled). Import alerts will come from FDA's published import-alert pages. We link to each source record and do not rehost the documents.
When does it arrive?
A weekly email digest. Checkout is not open yet; when it is, the digest goes to subscribers.
How do billing and cancellation work?
Monthly, renewing automatically, $39. Cancel anytime from the Stripe link in your receipt; cancellation takes effect at the end of the paid period.
How do I get in touch?
Email hello@fdasupplementwatch.com. That inbox is still being set up, so it may not receive mail yet.